Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Top Cited Papers
- 16 March 2000
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (11) , 763-769
- https://doi.org/10.1056/nejm200003163421103
Abstract
We evaluated the safety and efficacy of etanercept, a soluble tumor necrosis factor receptor (p75):Fc fusion protein, in children with polyarticular juvenile rheumatoid arthritis who did not tolerate or had an inadequate response to methotrexate.Keywords
This publication has 31 references indexed in Scilit:
- Juvenile rheumatoid arthritis in rochester, minnesota 1960–1993. Is the epidemiology changing?Arthritis & Rheumatism, 1996
- Measurement of health status in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1994
- Methotrexate in Juvenile Rheumatoid ArthritisDrug Safety, 1993
- First international conference on rheumatic diseases in pregnancyArthritis & Rheumatism, 1993
- The health assessment questionnaire 1992. Status and reviewArthritis & Rheumatism, 1992
- Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alphaClinical and Experimental Immunology, 1991
- Induction of Suppurative Arthritis in Rabbits by Haemophilus Endotoxin, Tumor Necrosis Factor- , and Interleukin-IThe Journal of Infectious Diseases, 1991
- Auranofin in the treatment of juvenile rheumatoid arthritisArthritis & Rheumatism, 1990
- Penicillamine and Hydroxychloroquine in the Treatment of Severe Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985